SCHEDULE: Vanguard Boosts GoodRx Stake to 9.33%
Beneficial Ownership Report (Schedule 13G)
The Vanguard Group has reported an increased beneficial ownership of 9.33% in GoodRx Holdings Inc, holding over 9.2 million shares.
Summary
- The Vanguard Group reported beneficial ownership of 9,207,340 shares of GoodRx Holdings Inc common stock.
- This represents 9.33% of the class of securities.
- Vanguard holds sole dispositive power over 8,612,246 shares and shared dispositive power over 595,094 shares.
- Vanguard holds shared voting power over 513,340 shares and no sole voting power.
- The filing was made as an investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E).
Sentiment
Score: 7
Explanation: A significant, passive stake by a major institutional investor like Vanguard is generally viewed as a positive indicator of stability and long-term interest in the company, though it doesn't reflect active management confidence.
Positives
- A significant stake by a major institutional investor like The Vanguard Group can signal long-term confidence in GoodRx Holdings Inc.
- Increased institutional ownership often contributes to market stability and liquidity for the stock.
Negatives
- No direct negatives are disclosed in this beneficial ownership report.
Risks
- This filing does not detail specific risks related to GoodRx Holdings Inc's operations or financial performance.
Future Outlook
NA
Industry Context
The Vanguard Group is one of the world's largest investment management companies, primarily known for its passively managed index funds and ETFs. Its significant stake in GoodRx Holdings Inc likely reflects the company's inclusion in various market indices that Vanguard's funds track, rather than an active investment decision based on specific company performance.
Stakeholder Impact
- Shareholders may view Vanguard's substantial and passive ownership as a positive sign of long-term institutional interest, potentially contributing to stock stability and investor confidence.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement |
| 10/30/2025 | Signature date of the filing |
Keywords
GoodRx Holdings Inc, Vanguard Group, Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake, asset management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.